Daishi Morimoto

Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+PD‐1− tumor‐infiltrating T cells in PD‐L1‐enriched tumor microenvironment

Y. Kodera, M. Sone, Maki Tanaka, 2021, International journal of cancer.

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers

Y. Kodera, B. Aleksic, S. Sumigama, 2018, Cancers.

Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

F. Sonohara, M. Kanda, S. Yamada, 2019, Annals of Surgical Oncology.

Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer

F. Sonohara, M. Kanda, S. Yamada, 2020, Pancreas.

Comparison of non‐invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma

F. Sonohara, M. Kanda, S. Yamada, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification

F. Sonohara, M. Kanda, S. Yamada, 2018, Pancreas.

Resection and Management of Schwannoma of the Transverse Colon

H. Tanabe, T. Yaguchi, T. Takase, 2014 .

Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)

Y. Kodera, K. Misawa, S. Morita, 2019, The British journal of surgery.

C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells

Y. Kodera, Maki Tanaka, D. Morimoto, 2021, Cells.

STING activator 2′3′‐cGAMP enhanced HSV‐1‐based oncolytic viral therapy

N. Mukoyama, M. Abdelmoneim, Shigeru Matsumura, 2024, Molecular oncology.